Survivor Story
Mary Catherine Riley is living cancer-free thanks to a clinical trial involving two targeted therapeutics for her stage 3 ovarian cancer.
Read Mary Catherine's Story
Mary Catherine Riley is living cancer-free thanks to a clinical trial involving two targeted therapeutics for her stage 3 ovarian cancer.
Read Mary Catherine's Story
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThe inaugural AACR Pediatric Cancer Progress Report highlights research-driven advances in the prevention, detection, and treatment of childhood cancers.
Read the ReportApril is Head and Neck Cancer Awareness Month. Learn about these types of cancer that develop in the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx.
Learn MoreTwenty-four eminent scientists whose pioneering discoveries have accelerated progress in cancer science and medicine have been elected Fellows of the AACR Academy, Class of 2026.
Learn MoreRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe official news website of the AACR Annual Meeting 2026. Stay up to date on the latest developments from the world’s premier cancer research event.
The AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn MoreThe AACR and its more than 61,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Cancer Progress Report 2025 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 62,600 members worldwide drive progress against cancer.
Donate Now
